Current Drug Targets

Editor-in-Chief:

Francis J. Castellino
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA

Back

Become EABM
Become Reviewer

Lanthionine Synthetase Component C-Like Protein 2: A New Drug Target for Inflammatory Diseases and Diabetes

Volume:15   Issue: 6
Pp: 565-572
Pinyi Lu, Raquel Hontecillas, Casandra W. Philipson and Josep Bassaganya-Riera
DOI: 10.2174/1389450115666140313123714

Recent Advances in Active Hepatic Targeting Drug Delivery System

Volume:15   Issue: 6
Pp: 573-599
Yang Wang, Hongliang Du and Guangxi Zhai
DOI: 10.2174/1389450115666140309232100

Dipeptidyl Peptidase IV Inhibitors: A New Paradigm in Type 2 Diabetes Treatment

Volume:15   Issue: 6
Pp: 600-621
Sridhara Janardhan and G. Narahari Sastry
DOI: 10.2174/1389450115666140311102638

Progress of HDAC Inhibitor Panobinostat in the Treatment of Cancer

Volume:15   Issue: 6
Pp: 622-634
Xiaoyang Li, Jian Zhang, Yuanchao Xie, Yuqi Jiang, Zhang Yingjie and Wenfang Xu
DOI: 10.2174/1389450115666140306152642

Emerging Pathways and Promising Agents with Possible Disease Modifying Effect in Osteoarthritis Treatment

Volume:15   Issue: 6
Pp: 635-661
Zdravko Jotanovic, Radovan Mihelic, Branko Sestan and Zlatko Dembic
DOI: 10.2174/1389450115666140306153115